Beam Therapeutics Inc.
US ˙ NasdaqGS ˙ US07373V1052

SecurityBEAM / Beam Therapeutics Inc.
InstitutionONEQ - Fidelity Nasdaq Composite Index Tracking Stock
Latest Disclosed Ownership27,845 shares
Latest Disclosed Value $ 440,786
ONEQ - Fidelity Nasdaq Composite Index Tracking Stock reports 0.47% increase in ownership of BEAM / Beam Therapeutics Inc.

On July 24, 2025 - ONEQ - Fidelity Nasdaq Composite Index Tracking Stock filed a NPORT-P form disclosing ownership of 27,845 shares of Beam Therapeutics Inc. (US:BEAM) valued at $440,786 USD as of May 31, 2025. The entity filed a previous NPORT-P on April 25, 2025 disclosing 27,715 shares of Beam Therapeutics Inc.. This represents a change in shares of 0.47% during the quarter. The current value of the position is $818,643 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-07-24 2025-05-31 NP BEAM THERAPEUTICS EC US07373V1052 27,845 130 0.47 441 -39.73 0.0058
2025-04-25 2025-02-28 NP BEAM THERAPEUTICS EC US07373V1052 27,715 702 2.60 730 -1.22 0.0098
2025-01-27 2024-11-30 NP BEAM THERAPEUTICS EC US07373V1052 27,013 -2,373 -8.08 739 -5.74 0.0100
2024-10-29 2024-08-31 NP BEAM THERAPEUTICS EC US07373V1052 29,386 -5,552 -15.89 784 -5.77 0.0116
2024-07-26 2024-05-31 NP BEAM THERAPEUTICS EC US07373V1052 34,938 2,221 6.79 832 -35.55 0.0132
2024-04-24 2024-02-29 NP BEAM THERAPEUTICS EC US07373V1052 32,717 527 1.64 1,292 42.97 0.0216
2024-01-24 2023-11-30 NP BEAM THERAPEUTICS EC US07373V1052 32,190 -2,677 -7.68 904 11.76 0.0173
2023-10-27 2023-08-31 NP BEAM THERAPEUTICS EC US07373V1052 34,867 15,218 77.45 808 29.07 0.0158
2023-07-26 2023-05-31 NP BEAM THERAPEUTICS EC US07373V1052 19,649 60 0.31 627 -20.56 0.0135
2023-04-27 2023-02-28 NP BEAM THERAPEUTICS EC US07373V1052 19,589 450 2.35 788 -10.86 0.0193
2023-01-26 2022-11-30 NP BEAM THERAPEUTICS EC US07373V1052 19,139 470 2.52 884 -13.25 0.0221
2022-10-26 2022-08-31 NP BEAM THERAPEUTICS EC US07373V1052 18,669 4,989 36.47 1,019 111.85 0.0255
2022-07-29 2022-05-31 NP BEAM THERAPEUTICS EC US07373V1052 13,680 416 3.14 481 -53.71 0.0123
2022-04-28 2022-02-28 NP BEAM THERAPEUTICS EC US07373V1052 13,264 208 1.59 1,039 0.58 0.0241
2022-01-25 2021-11-30 NP BEAM THERAPEUTICS EC US07373V1052 13,056 344 2.71 1,033 -26.74 0.0216
2021-10-26 2021-08-31 NP BEAM THERAPEUTICS EC US07373V1052 12,712 264 2.12 1,410 44.91 0.0309
2021-07-22 2021-05-31 NP BEAM THERAPEUTICS EC US07373V1052 12,448 48 0.39 974 -11.95 0.0242
2021-04-23 2021-02-28 NP BEAM THERAPEUTICS EC US07373V1052 12,400 -3,921 -24.02 1,105 35.42 0.0288
2021-01-20 2020-11-30 NP BEAM THERAPEUTICS EC US07373V1052 16,321 16,321 816 0.0244
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.